The company said members of its executive management team will take part in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, at 4:30 p.m. (PT), the company said on January 2, 2024.

8-KRegulation FD DisclosureFiled Jan 2, 2024Period of report Jan 2, 2024Summary published (UTC) Oct 29, 2026

Key points

AI summary

The company said members of its executive management team will take part in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, at 4:30 p.m. (PT), the company said on January 2, 2024.
Labcorp said a live audio webcast of the fireside chat will be available on its Investor Relations website at ir.Labcorp.com and will be archived for replay.
Labcorp filed this 8-K under Item 7.01, Regulation FD Disclosure, and attached a press release dated January 2, 2024 as Exhibit 99.1.
In its boilerplate, the company said it has more than 60,000 employees supporting clients in over 100 countries, was involved with over 80% of the new drugs approved by the FDA in 2022, and performed more than 600 million tests.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Labcorp to Participate in J.P. Morgan Healthcare Conference Fireside Chat

The company said members of its executive management team will take part in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, at 4:30 p.m. (PT), the company said on January 2, 2024.

Source · Based on the filing body and exhibits

Live Audio Webcast and Archived Replay

Labcorp said a live audio webcast of the fireside chat will be available on its Investor Relations website at ir.Labcorp.com and will be archived for replay.

Source · Based on the filing body and exhibits

Regulation FD Disclosure and Press Release Exhibit

Labcorp filed this 8-K under Item 7.01, Regulation FD Disclosure, and attached a press release dated January 2, 2024 as Exhibit 99.1.

Source · Based on the filing body and exhibits

Operational Scale in Company Description

In its boilerplate, the company said it has more than 60,000 employees supporting clients in over 100 countries, was involved with over 80% of the new drugs approved by the FDA in 2022, and performed more than 600 million tests.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.